←Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma
Stephen Ansell
MBChB, PhD
🏢Mayo Clinic🌐USA
Chair, Division of Hematology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Stephen Ansell led the earliest trials of PD-1 blockade in relapsed Hodgkin lymphoma demonstrating exceptional response rates and established checkpoint inhibitors as a new standard for relapsed disease. He chairs hematology at Mayo Clinic.
Share:
🧪Research Fields 研究领域
nivolumab Hodgkin
pembrolizumab Hodgkin
PD-1 lymphoma
tumor microenvironment
relapsed Hodgkin
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Stephen Ansell 的研究动态
Follow Stephen Ansell's research updates
留下邮箱，当我们发布与 Stephen Ansell（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment